This inventor holds 4 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Illinois, Vanderbilt University. Active years: 2016-2021.
Company Filing History:
4 out of 3,690 
3 out of 2,421 
1 out of 1,218 
Years Active: 2016-2021
Title: Vadim Gaponenko: Innovator in Peptide Research
Introduction
Vadim Gaponenko is a notable inventor based in Naperville, IL (US). He has made significant contributions to the field of peptide research, particularly in the area of CCR3-mediated diseases. With a total of 4 patents to his name, Gaponenko's work has the potential to impact various medical conditions.
Latest Patents
One of Gaponenko's latest patents involves a peptide analog that targets the C–C chemokine receptor 3 (CCR3). This peptide exhibits biased antagonism by binding to and inhibiting ligand-mediated signaling and chemotaxis. Additionally, it promotes the internalization and degradation of CCR3. The method outlined in this patent aims to treat, prevent, or ameliorate symptoms associated with eosinophil- or CCR3-mediated diseases or conditions.
Career Highlights
Throughout his career, Gaponenko has worked with prominent organizations, including the United States of America, as represented by the Secretary, Department of Health and Human Services, and the University of Illinois. His research has contributed to advancements in understanding and treating various health conditions.
Collaborations
Gaponenko has collaborated with notable colleagues such as Nadya Tarasova and Steven Jules Ackerman. These partnerships have further enriched his research and innovation efforts.
Conclusion
Vadim Gaponenko's work in peptide research exemplifies the impact of innovative thinking in the medical field. His patents and collaborations highlight his commitment to advancing healthcare solutions.